Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Collegium Pharmaceutical (COLL) Cost of Revenue (2016 - 2026)

Collegium Pharmaceutical has reported Cost of Revenue over the past 10 years, most recently at $21.6 million for Q4 2025.

  • For Q4 2025, Cost of Revenue fell 74.18% year-over-year to $21.6 million; the TTM value through Dec 2025 reached $150.9 million, down 40.62%, while the annual FY2025 figure was $95.4 million, 62.45% down from the prior year.
  • Cost of Revenue for Q4 2025 was $21.6 million at Collegium Pharmaceutical, down from $24.7 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $83.7 million in Q4 2024 and troughed at $11.9 million in Q4 2021.
  • A 5-year average of $35.6 million and a median of $30.3 million in 2022 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: surged 306.1% in 2024 and later tumbled 74.18% in 2025.
  • Year by year, Cost of Revenue stood at $11.9 million in 2021, then surged by 215.56% to $37.6 million in 2022, then tumbled by 45.14% to $20.6 million in 2023, then surged by 306.1% to $83.7 million in 2024, then tumbled by 74.18% to $21.6 million in 2025.
  • Business Quant data shows Cost of Revenue for COLL at $21.6 million in Q4 2025, $24.7 million in Q3 2025, and $24.1 million in Q2 2025.